Comparative Effectiveness of Upadacitinib and Tofacitinib in Ulcerative Colitis: A US Propensity-Matched Cohort Study.

Gursimran S KochharHimsikhar KhataniarVipul JairathFrancis A Farraye Aakash Desai

Published in: The American journal of gastroenterology (2024)

This study utilizing real-world data showed that upadacitinib was associated with improved disease-specific outcomes at 12 months compared with tofacitinib in patients with UC.

Keyphrases

ulcerative colitis
rheumatoid arthritis
big data
metabolic syndrome
deep learning
weight loss